EUVIMEDEUVIMED entdecken
Open Access

Endoscopic response to topical steroids is associated with a need for fewer future esophageal dilations

Timothy S Gee, Sean S LaFata, Hannah L Thel, Brenderia A Cameron, Angela Z Xue, Akshatha Kiran, Adolfo A Ocampo, Justin McCallen, Christopher J Lee, Stephanie A Borinsky, Walker D Redd, Trevor S Barlowe und 5 weitere

Diseases of the Esophagus · 2025

DOI: 10.1093/dote/doaf032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diseases of the Esophagus, 2025. Verfasst von Timothy S Gee und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Gastroenterology and Hepatology, Center for Esophageal Diseases and Swallowing, University of North Carolina Scho…. Hauptthemen laut MEDLINE: Eosinophilic Esophagitis, Dilatation, Esophagoscopy, Glucocorticoids. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The eosinophilic esophagitis (EoE) Endoscopic Reference Score (EREFS) measures endoscopic severity. While a score of ≤2 has been proposed for endoscopic response, it is unknown whether achieving this threshold results in clinically important outcomes. We aimed to determine whether an EREFS response to topical steroids (tCS) is associated with a decreased need for future esophageal dilation. In this retrospective cohort study, we included patients with a new diagnosis of EoE who underwent esophageal dilation, were then treated with tCS, and had at least two follow-up endoscopies. Endoscopic response was defined as EREFS ≤2. Histological and global symptom responses were recorded. We compared patients with and without endoscopic response and calculated the number of subsequent dilations in each group. Of 113 EoE patients, 55 (49%) had endoscopic response post-tCS. Compared to endoscopic non-responders, responders were older (43.4 vs 34.4 years; p = 0.001) and had lower EREFS (4.4 ± 1.6 vs. 6.3 ± 1.5; p < 0.001) at baseline. EREFS responders required fewer dilations on their initial post-treatment endoscopy (65% vs 90%; p = 0.002) and had greater symptom (92% vs 64%; p = 0.005) and histologic responses (82% vs 24% <15 eos/hpf; p < 0.001). Over the median follow-up time of 1106 days, EREFS responders required fewer dilations than non-responders (4.5 ± 2.9 vs 6.2 ± 4.5; p = 0.03). Endoscopic responders to tCS required fewer esophageal dilations compared to non-responders. Responders also had better symptom and histologic responses. These results provide evidence that endoscopic response is associated with important clinical outcomes including a reduction in future esophageal dilations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Eosinophilic EsophagitisDilatationEsophagoscopyGlucocorticoidsHumansRetrospective StudiesMaleFemaleAdultMiddle AgedTreatment OutcomeAdministration, TopicalSeverity of Illness IndexEsophagus

Stichwörter der Autor:innen

dilatationeosinophilic esophagitisesophagoscopysteroidstreatment outcome

Substanzen

Glucocorticoids

Autor:innen und Institutionen

  • Department of Medicine, Division of Gastroenterology and Hepatology, Center for Esophageal Diseases and Swallowing, University of North Carolina School of Medicine, 101 Manning Drive, Chapel Hill, NC 27599, USA.
  • Department of Pediatrics; Division of Pediatric Gastroenterology, University of North Carolina School of Medicine, 101 Manning Drive, Chapel Hill, NC 27516, USA.
  • Department of Medicine, Division of Allergy and Immunology, University of North Carolina School of Medicine, 101 Manning Drive, Chapel Hill, NC 27516, USA.
  • Department of Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL 32224, USA.
  • Department of Medicine, Division of Gastroenterology and Hepatology, Center for Gastrointestinal Biology and Disease, University of North Carolina School of Medicine, 101 Manning Drive, Chapel Hill, NC 27516, USA.

Förderung

  • NIH HHS
  • NIH

Zitieren

APA

Gee, T. S., LaFata, S. S., Thel, H. L., Cameron, B. A., Xue, A. Z., Kiran, A., Ocampo, A. A., McCallen, J., Lee, C. J., Borinsky, S. A., Redd, W. D., Barlowe, T. S., Kaakati, R. N., Cotton, C. C., Eluri, S., Reed, C. C., & Dellon, E. S. (2025). Endoscopic response to topical steroids is associated with a need for fewer future esophageal dilations. Diseases of the Esophagus. https://doi.org/10.1093/dote/doaf032

Vancouver

Gee TS, LaFata SS, Thel HL, Cameron BA, Xue AZ, Kiran A, et al. Endoscopic response to topical steroids is associated with a need for fewer future esophageal dilations. Diseases of the Esophagus. 2025. doi:10.1093/dote/doaf032

BibTeX
@article{Gee2025,
  author = {Gee, Timothy S and LaFata, Sean S and Thel, Hannah L and Cameron, Brenderia A and Xue, Angela Z and Kiran, Akshatha and Ocampo, Adolfo A and McCallen, Justin and Lee, Christopher J and Borinsky, Stephanie A and Redd, Walker D and Barlowe, Trevor S and Kaakati, Rayan N and Cotton, Cary C and Eluri, Swathi and Reed, Craig C and Dellon, Evan S},
  title = {Endoscopic response to topical steroids is associated with a need for fewer future esophageal dilations},
  journal = {Diseases of the Esophagus},
  year = {2025},
  doi = {10.1093/dote/doaf032}
}
Kostenlos starten →